Results per Page:
Encouraged by a physician he saw in the Philippines, stage 3 lung cancer patient turned to Fred Hutch
Proton therapy was the right treatment plan for Gerardo Bada
Cell free DNA profiling may unlock the key to studying small cell lung cancer
MacPherson and Ha Labs in the Division of Human Biology
20 years since Fred Hutch president helped make EGFR discovery, woman with stage 4 lung cancer is thriving
Dr. Tom Lynch described how targeted therapies could dramatically improve patient outcomes
For a fourth bout of cancer – of the lung this time – Art turned to proton therapy
After three bouts with lymphoma, Art now faced lung cancer.
Is it cancer? A combination non-invasive approach to determine if indeterminate pulmonary nodules are cancerous
From Dr. Paul Lampe, Translational Research Program and Cancer Epidemiology, Prevention and Control of the Cancer Consortium, and Dr. Paul Kinahan, University of Washington.
Lung cancer expert Dr. McGarry Houghton receives Satya and Rao Remala Family Endowed Chair
New sustained funding will represent Fred Hutch’s first endowed chair for lung cancer
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Out of pocket costs and patient outcomes in EGFR and ALK positive NSCLC
From the Goulart and Ramsey Group
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
Natural language processing as a research aid
From the Divisions of Clinical Research and Public Health Sciences
Good News at Fred Hutch
<p>Dr. Aude Chapuis named Damon Runyon Clinical Investigator; Dr. Jonathan Bricker receives $3.1M NCI grant to test quit-smoking smartphone app; Dr. Hans-Peter Kiem appointed chair of NIH Recombinant DNA Advisory Committee; Dr. Julie Overbaugh receives award from Association for Women in Science</p>